Overview
Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
To evaluate the effectiveness of low molecular weight hyaluronic acid oral tablets for the treatment of atrophic vaginitis.Phase:
Phase 4Details
Lead Sponsor:
AGUNCO Obstetrics and Gynecology CentreTreatments:
Hyaluronic Acid
Criteria
Inclusion Criteria:- at least 12 months postmenopausal
- mucosal atrophy and the main bothersome related symptoms, such as itching, burning,
and dyspareunia.